See the DrugPatentWatch profile for vascepa
Based on the information provided, I was unable to find specific details regarding whether income levels are considered for Vascepa patient assistance. However, I did find some general information about patient assistance programs for expensive drugs that might be helpful.
Vascepa is a prescription medication used to lower triglyceride levels in adults. The drug is manufactured by Amarin Pharma Inc. and can be quite expensive, leading some patients to seek assistance to cover the costs.
Patient assistance programs are often available for expensive medications like Vascepa. These programs are typically sponsored by pharmaceutical companies, non-profit organizations, or government agencies to help patients afford their medications. While the specific criteria for eligibility may vary, income level is often a factor considered in these programs [1].
Amarin Pharma Inc. offers a patient assistance program for Vascepa called the Amarin Cares program [2]. According to the program's website, patients may be eligible for assistance if they meet certain income and insurance criteria. However, the website does not provide specific details about how income levels are considered for eligibility [3].
Patients interested in applying for the Amarin Cares program can contact the program directly to determine if they are eligible for assistance [3]. It is also worth noting that there may be other patient assistance programs available for Vascepa, and patients are encouraged to explore all available options.
In summary, while there is no specific information available about how income levels are considered for Vascepa patient assistance, it is common for patient assistance programs to take income into account when determining eligibility. Patients interested in applying for assistance with Vascepa costs can contact the Amarin Cares program to determine if they are eligible for assistance.
Sources:
1. "Patient Assistance Programs." National Institute on Aging, U.S. Department of Health and Human Services, 15 Sept. 2021, www.nia.nih.gov/health/patient-assistance-programs.
2. "Amarin Cares Program." Amarin Cares, Amarin Pharma Inc., www.amarincares.com/.
3. "Vascepa (Icosapent Ethyl) - Drug Patent Watch." DrugPatentWatch, 11 Jan. 2023, www.drugpatentwatch.com/drugs/vascepa.